001     143501
005     20240229112554.0
024 7 _ |a 10.1016/j.jpain.2019.04.002
|2 doi
024 7 _ |a pmid:31009765
|2 pmid
024 7 _ |a 1526-5900
|2 ISSN
024 7 _ |a 1528-8447
|2 ISSN
024 7 _ |a altmetric:59388744
|2 altmetric
037 _ _ |a DKFZ-2019-01085
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Herpertz, Sabine C
|b 0
245 _ _ |a Oxytocin Effects on Pain Perception and Pain Anticipation.
260 _ _ |a New York, NY
|c 2019
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1573649462_20580
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a There is an ongoing debate whether the neuropeptide oxytocin (OT) modulates pain processing in humans. This study differentiates behavioral and neuronal OT effects on pain perception and pain anticipation by using a Pavlovian conditioning paradigm. Forty-six males received intranasally administered OT in a randomized double-blind, placebo-controlled group design. Although OT exerted no direct effect on perceived pain, OT was found to modulate the blood-oxygen-level-dependent response in the ventral striatum for painful versus warm unconditioned stimuli (US) and to decrease activity in the anterior insula with repeated thermal pain stimuli. Regarding pain anticipation, OT increased responses to CSpain versus CSminus in the nucleus accumbens. Furthermore, in the OT condition increased correct expectations, particularly for the most certain CS-US associations (CSminus and CSpain), were found as well as greatest deactivations in the right posterior insula in response to the least certain condition (CSwarm) with posterior insula activity and correct expectancies being positively correlated. In conclusion, OT appears to have both, a direct effect on pain processing via the ventral striatum and by inducing habituation in the anterior insula as well as on pain anticipation by boostering associative learning in general and the neuronal conditioned fear of pain response in particular. PERSPECTIVE: The neuropeptide oxytocin (OT) has recently raised the hope to offer a novel avenue for modulating pain experience. This study found OT to modulate pain processing and to facilitate the anticipation of pain inspiring further research on OT effects on the affective dimension of the pain experience.
536 _ _ |a 319H - Addenda (POF3-319H)
|0 G:(DE-HGF)POF3-319H
|c POF3-319H
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Schmitgen, Mike M
|b 1
700 1 _ |a Fuchs, Christine
|b 2
700 1 _ |a Roth, Corinna
|b 3
700 1 _ |a Wolf, Robert Christian
|b 4
700 1 _ |a Bertsch, Katja
|b 5
700 1 _ |a Flor, Herta
|b 6
700 1 _ |a Grinevich, Valery
|0 P:(DE-He78)b2142a2557ce071790760d0126e259d3
|b 7
|u dkfz
700 1 _ |a Boll, Sabrina
|b 8
773 _ _ |a 10.1016/j.jpain.2019.04.002
|g p. S1526590018310526
|0 PERI:(DE-600)2040378-1
|n 10
|p 1187-1198
|t The journal of pain
|v 20
|y 2019
|x 1526-5900
909 C O |o oai:inrepo02.dkfz.de:143501
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)b2142a2557ce071790760d0126e259d3
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|2 G:(DE-HGF)POF3-300
|v Addenda
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J PAIN : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)V078-20160331
|k V078
|l AG Neuropeptide
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)V078-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21